CUSIP: G1125A116
What is CUSIP G1125A116?
CUSIP G1125A116 identifies BIOTW - BIOTECH ACQUISITION COMPANY - *W EXP 11/30/202 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP G1125A116:
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2023 Q1 | 0 | $0 | -$658,535 | 0 | |
| 2022 Q4 | 6,605,990 | $668,535 | +$2,071 | $0.06 | 44 |
| 2022 Q3 | 6,652,527 | $391,000 | +$5,961 | $0.06 | 38 |
| 2022 Q2 | 4,705,860 | $670,000 | -$371,466 | $0.09 | 30 |
| 2022 Q1 | 7,444,457 | $2,252,000 | -$619,003 | $0.24 | 48 |
| 2021 Q4 | 7,803,219 | $5,531,000 | +$1,607,242 | $0.66 | 53 |
| 2021 Q3 | 5,943,095 | $3,909,000 | +$360,417 | $0.66 | 36 |
| 2021 Q2 | 5,399,999 | $4,635,000 | +$1,719,940 | $0.86 | 32 |
| 2021 Q1 | 3,452,362 | $2,077,000 | +$2,077,000 | $0.60 | 20 |